Genome-wide association meta-analysis identifies GP2 gene risk variants for pancreatic cancer

Nat Commun. 2020 Jun 24;11(1):3175. doi: 10.1038/s41467-020-16711-w.

Abstract

Pancreatic cancer is the fourth leading cause of cancer-related deaths in Japan. To identify risk loci, we perform a meta-analysis of three genome-wide association studies comprising 2,039 pancreatic cancer patients and 32,592 controls in the Japanese population. Here, we identify 3 (13q12.2, 13q22.1, and 16p12.3) genome-wide significant loci (P < 5.0 × 10-8), of which 16p12.3 has not been reported in the Western population. The lead single nucleotide polymorphism (SNP) at 16p12.3 is rs78193826 (odds ratio = 1.46, 95% confidence interval = 1.29-1.66, P = 4.28 × 10-9), an Asian-specific, nonsynonymous glycoprotein 2 (GP2) gene variant. Associations between selected GP2 gene variants and pancreatic cancer are replicated in 10,822 additional cases and controls of East Asian origin. Functional analyses using cell lines provide supporting evidence of the effect of rs78193826 on KRAS activity. These findings suggest that GP2 gene variants are probably associated with pancreatic cancer susceptibility in populations of East Asian ancestry.

Publication types

  • Meta-Analysis
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Asians / genetics
  • Cell Line, Tumor
  • Databases, Genetic
  • GPI-Linked Proteins / genetics*
  • GPI-Linked Proteins / metabolism
  • Genetic Loci
  • Genetic Pleiotropy
  • Genetic Predisposition to Disease / genetics*
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Pancreatic Neoplasms / genetics*
  • Polymorphism, Single Nucleotide

Substances

  • GP2 protein, human
  • GPI-Linked Proteins